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What’s already known about this topic? 
・Epidermal keratinocytes and dermal fibroblasts express functional TLRs. 
・SAA are produced mainly by hepatocytes but also a variety of cells including immune 
cells, endothelial cells, synoviocytes, and epidermal keratinocytes. 
・SAA induces the expression of SAA itself via TLR1/2 in epidermal keratinocytes. 
What does this study add? 
・TLR ligands induce SAA expression in epidermal keratinocytes and dermal fibroblasts. 
・SAA induces the expression of SAA itself via TLR1/2 in dermal fibroblasts. 
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Abstract 
Background: Toll-like receptors (TLRs) play critical roles in innate immune response by 
sensing pathogen- or damage-associated molecular patterns. Epidermal keratinocytes and 
dermal fibroblasts also produce proinflammatory cytokines and chemokines under the 
stimulation with TLR ligands. Serum amyloid A (SAA) is an essential factor in the 
pathogenesis of secondary amyloidosis, and also has immunomodulatory functions. SAA 
are produced mainly by hepatocytes but also a variety of cells including immune cells, 
endothelial cells, synoviocytes, and epidermal keratinocytes. However, SAA expression in 
human dermal fibroblasts has not been shown so far. 
Aim: To investigate the effect of TLR ligands on SAA expression in epidermal 
keratinocytes and dermal fibroblasts. 
Methods: We investigated whether TLR ligands induce the expression of SAA in normal 
human epidermal keratinocytes (NHEKs) and dermal fibroblasts (NHDFs) by using qPCR 
and ELISA. The effect of SAA on SAA itself expression in NHDFs was also studied. 
Results: SAA expression was induced via NF-κB by TLR1/2, 3, 5, and 2/6 ligands in 
NHEKs. In NHDFs, TLR1/2 and 2/6 ligands increased the expression. SAA further induced 
the expression of SAA itself via TLR1/2 and NF-κB in NHDFs, as previously reported for 
NHEKs. 
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Conclusions: Our results provide new evidence that the skin’s innate immune response 
contributes to the production of SAA which might lead to the increase in the risk of 
systemic complication such as secondary amyloidosis of recessive dystrophic 
epidermolysis bullosa patients. 
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INTRODUCTION 
The skin is the first line of defense against the external environment of the body.
1
 Therefore,
in the skin, the nonspecific quick inflammatory reaction, or the innate immune system, is 
necessary, and it is comprised of keratinocytes, neutrophils, macrophages, and more.
1
 Skin
inflammation by injury starts when Toll-like receptors (TLRs) in keratinocytes at the 
injured sites recognize molecules derived from microbes that are called 
pathogen-associated molecular patterns (PAMPs), or molecules derived from injured cells 
that are called damage-associated molecular patterns (DAMPs).
2-5
 PAMPs and DAMPs are
also recognized by nucleotide oligomerization domain (NOD)-like receptors (NLRs), 
retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), C-type lectin receptors, 
receptor for advanced glycation end products (RAGE), and so on.
6
 In addition to
keratinocytes, another type of resident structural cells, fibroblasts, also express TLRs, and 
can also produce proinflammatory cytokines and chemokines, the production of which 
triggers and enhances skin inflammation.
2
Serum amyloid A (SAA) is a 12-kDa acute phage protein encoded by SAA1-4 
located on chromosome 11 in human.
7
 SAA1 and SAA2 encode acute phage proteins, SAA3
is a pseudogene, and SAA4 is constitutively expressed.
7
 SAA is induced by
Page 5 of 29 Clinical and Experimental Dermatology
6 
proinflammatory cytokines such as TNF-α and IL-6, synthesized mainly by the liver, and 
predominantly bound to high density lipoprotein in the blood.
7
 Secondary amyloidosis (SA)
is a critical disease characterized by the extracellular tissue deposition of the insoluble 
amyloid fibrils derived from SAA, and it complicates any chronic inflammatory diseases 
including rheumatoid arthritis.
8
 The persistent high concentration of SAA in the sera is
reported a prerequisite for the development of SA.
9
 SAA are produced by not only
hepatocytes but also a variety of cells including immune cells, endothelial cells, and 
synoviocytes.
7
 In addition, SAA is also considered to act as DAMP molecules.
6
 In
rheumatoid arthritis, SAA expression is increased in synoviocytes of the joints, and it is 
considered to act as the exacerbation factor of the local inflammation because it has 
proinflammatory functions.
7,10
 Epidermal keratinocytes also express SAA,
11-13
 however, the
expression in human dermal fibroblasts has not been reported so far. 
Epidermolysis bullosa (EB) is an inherited blistering disorder of the skin and 
mucosal membranes.
14
 EB is caused by mutations in keratin or collagen genes, and has
various subtypes. 
14
 Recessive dystrophic epidermolysis bullosa (RDEB) is an uncommon
and severe subtype EB characterized by inherently fragile skin and recurrent blister 
formation occurring over the whole body within weeks after birth, and caused by mutations 
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in the type VII collagen gene COL7A1.
14
 Patients with RDEB show persistent, widespread
skin ulcers and develop complications such as oesophageal stricture, infection, 
pseudosyndactyly, renal failure, cutaneous squamous cell carcinoma, and SA.
15,16
 The
expression of SAA has already been reported to be elevated in the sera of patients with 
RDEB.
17
 In addition, we reported that such elevation is persistent in these patients.
18
However, the mechanism of the increase in SAA expression in patients with RDEB has not 
been shown so far. 
Here we show that TLR ligands induce SAA expression via NF-κB in epidermal 
keratinocytes and dermal fibroblasts, and that SAA further induces the expression of SAA 
itself in dermal fibroblasts via TLR1/2 and NF-κB. 
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METHODS 
Cell culture and stimuli 
Normal human epidermal keratinocytes (NHEKs) were obtained from Invitrogen/Cascade 
Biologics (Portland, OR, U.S.A.) and grown in serum-free EpiLife Medium 
(Invitrogen/Cascade Biologics) containing 0.06 mM Ca
2+
 and 1× EpiLife Defined Growth
Supplement (Invitrogen/Cascade Biologics) at 37 °C under standard tissue culture 
conditions. Normal human dermal fibroblasts (NHDFs) were obtained from 
Invitrogen/Cascade Biologics and grown in Medium 106S (Cascade Biologics/Invitrogen) 
containing Low Serum Growth Supplements (Cascade Biologics/Invitrogen). Cultures were 
maintained for up to eight passages in these media with the addition of 100 U/ml penicillin, 
100 µg/ml streptomycin and 0.25 µg/ml amphotericin B. 
Cells were stimulated with Pam3CSK4 (10 µg/ml; InvivoGen, San Diego, CA, 
U.S.A.), polyinosinic:polycytidylic acid (poly(I:C), 10 µg/ml; InvivoGen), 
lipopolysaccharide (LPS, 10 µg/ml; InvivoGen), flagellin (100 ng/ml; InvivoGen), 
macrophage-activating lipopeptide (MALP)-2 (100 ng/ml; Alexis Biochemicals, San Diego, 
CA, U.S.A.), ODN M362 (2 µM; InvivoGen), or recombinant human SAA (10
-8
-10
-6
 M;
PeproTech, Rocky Hill, NJ, U.S.A.) for 24 h. After cell stimulation, the total cell media was 
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stored at -20°C until analysis. RNA was extracted using TRIzol reagent (Invitrogen, 
Carlsbad, CA, U.S.A.) after supernatant collection. RNA was stored at -80°C. 
Small interfering RNA (siRNA) transfection 
NHEKs and NHDFs were transfected with siRNA control or specific siRNA for NF-κB p65 
(Cell Signaling Technology, Danvers, MA, U.S.A.), TLR1, or TLR2 (Santa Cruz 
Biotechnology, Santa Cruz, CA, U.S.A.) using Lipofectamine RNAiMax (Invitrogen). After 
24 h of transfection, the cells were stimulated with TLR ligands or SAA for another 24 h. 
Neutralization of TLR1/2 
For the neutralization of TLR1/2, NHDFs were incubated with TLR1- or 
TLR2-neutralizing antibody (5 µg/ml; InvivoGen) or control IgG for 30 min. Cells were 
then stimulated with SAA for 24 h. 
Quantitative real time-polymerase chain reaction (qPCR) 
Complementary DNA (cDNA) was synthesized from RNA by the iScript cDNA Synthesis 
Kit (Bio-Rad Laboratories, Hercules, CA, U.S.A.) as described by the manufacturer’s 
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protocol. TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, U.S.A.) 
were used to analyse expression of SAA1/2 (assay ID: Hs00761940_s1), RELA 
(Hs00153294_m1), TLR1 (Hs00413978_m1), and TLR2 (Hs00610101_m1) as described in 
the instructions from the manufacturer (User Bulletin #2; Applied Biosystems). GAPDH 
mRNA was assessed as an internal control to validate RNA, and was detected with the 
probe VIC-CATCCATGACAACTTTGGTA-MGB and the primers 
5'-CTTAGCACCCCTGGCCAAG-3' and 5'-TGGTCATG AGTCCTTCCACG-3'. Each 
mRNA expression was calculated relative to expression of GAPDH mRNA, and all data are 
presented as fold changes against each control (mean from non-stimulated cells). 
Enzyme-linked immunosorbent assay (ELISA) 
SAA in culture media were measured by commercial sandwich ELISA kits following the 
manufacturer’s instructions (SAA Human ELISA Kit KHA0012, Invitrogen). Culture 
media were concentrated 20 times by Amicon Ultra-4 (Millipore-Amicon, Bedford, MA, 
U.S.A.) to detect SAA. Absorbance at 450 nm was determined using SH-1000Lab 
microplate reader (Corona Electric, Hitachinaka, Japan). 
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Statistical Analysis 
Student’s t-test was used to determine significance between the two groups. One-way 
analysis of variance with Tukey’s test was used to determine significance among more than 
two groups. The analyses were performed by Prism software (version 4; GraphPad 
Software, La Jolla, CA, U.S.A.). Results are expressed as mean ± standard error of the 
mean (SEM). Values of P<0.05 were considered significant. 
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RESULTS 
TLR ligands induce the expression of SAA in epidermal keratinocytes and dermal 
fibroblasts 
First of all, we investigated the effects of TLR ligands on the expression of SAA in NHEKs 
and NHDFs. Among a panel of TLR ligands, Pam3CSK4 (TLR1/2), poly(I:C) (TLR3), 
flagellin (TLR5), and MALP-2 (TLR2/6) significantly induced SAA expression at both the 
transcript and protein synthesis levels in NHEKs (Fig. 1a, b). In NHDFs, among a panel of 
TLR ligands, both Pam3CSK4 and MALP-2 significantly induced SAA expression (Fig. 1c, 
d). 
TLR signalling has been reported to induce proinflammatory cytokines through 
NF-κB. 
19
 The knockdown of p65 (a subunit of NF-κB) by siRNA significantly suppressed
the induction of SAA by Pam3CSK4, poly (I:C), flagellin, and MALP-2 in NHEKs (Fig. 2a, 
c). As with NHEKs, knock-down of p65 significantly suppressed the induction of SAA by 
Pam3CSK4 and MALP-2 in NHDFs (Fig. 2b, d). 
SAA induces the expression of SAA itself through NF-κB in dermal fibroblasts 
SAA, a precursor of amyloid protein, potently activates immunocytes and induces 
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proinflammatory cytokines and chemokines.
7
 Previously SAA is shown to induce IL-6
expression in dermal fibroblasts.
20
 We have reported that SAA induces the expression of
SAA itself in epidermal keratinocytes.
11
 We therefore investigated whether SAA could
enhance inflammatory responses in an autocrine/paracrine manner in dermal fibroblasts. As 
expected, SAA induced the expression of SAA itself in NHDFs in a dose-dependent 
manner (Fig. 3a). Since SAA is also reported to activate NF-κB signalling,
7,20
 we knocked
down p65 and confirmed that the induction of SAA by SAA was significantly inhibited in 
NHDFs (Fig. 3b). 
SAA acts through TLR1/2 to induce the expression of SAA itself in dermal fibroblasts 
O’Reilly et al showed that SAA induces IL-6 expression via TLR2 but not TLR4 in dermal 
fibroblasts.
20
 In epidermal keratinocytes, SAA is reported to induce the expression of SAA
itself via TLR1/2 heterodimer.
11
 Our present experiments revealed that TLR1 and TLR2
siRNA significantly inhibited the SAA induction by SAA in NHDFs (Fig. 4a, b, c). TLR1 
and TLR2-neutralizing antibody also significantly inhibited the induction of SAA itself by 
SAA in NHDFs (Fig. 4d). These results suggest that SAA acts through TLR1/2 heterodimer 
to induce the expression of SAA in dermal fibroblasts, as for epidermal keratinocytes. 
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DISCUSSION 
Previous studies have shown that TLR3 and 4 ligands induce SAA expression in airway 
epithelial cells and hepatocytes, respectively.
21,22
 In the present study, we demonstrated that
SAA production was induced under stimulation with several TLR ligands in epidermal 
keratinocytes and dermal fibroblasts. Among a panel of TLR ligands, TLR1/2, 3, 5 and 2/6 
significantly induced SAA expression in NHEKs. TLR7 and TLR8 ligands were not 
evaluated in NHEKs , because these receptors were not constitutively detectable in cultured 
keratinocytes.
23
 In NHDFs, among a panel of TLR ligands, TLR1/2 and 2/6 ligands induced
SAA expression at both the transcript and protein synthesis levels. TLR5, TLR7, and TLR8 
ligands were not evaluated in NHDFs, because these receptors were not constitutively 
detectable in cultured fibroblasts. SAA is one of the acute phage proteins and is considered 
to be synthesized mainly in the liver.
7,12
 We also demonstrated that the induction of SAA by
TLR ligands in epidermal keratinocytes and dermal fibroblasts was NF-κB-dependent, 
which is consistent with our previous report of SAA induction in keratinocytes.
11
The role of SAA in normal skin is not clearly shown so far, but it is thought to 
contribute to innate immunity in the skin because it has the capacities to activate several 
types of cells including neutrophils, monocytes, and mast cells, and induce inflammatory 
Page 14 of 29Clinical and Experimental Dermatology
15 
cytokines and chemokines.
7
 We further demonstrated that SAA induces the expression of
SAA itself in NHDFs as previously reported for NHEKs,
11
 suggesting that SAA can
enhance inflammatory reactions in an autocrine/paracrine manner. Our results also showed 
that the induction of both SAA by SAA depends on NF-κB in NHDFs. TLR2, TLR4, CD36, 
formyl peptide receptor-like 1 (FPRL1), and receptor of advanced glycation end-products 
(RAGE) have been reported as receptors for SAA.
7
 Nucleotide binding and oligomerization
domain-like receptor family pyrin domain-containing 3 may also be involved in SAA 
signalling.
7
 The findings of the present study indicate that TLR1/2 is, at least in part,
involved in the induction of SAA by SAA in NHDFs. 
Yamanaka et al. demonstrated that keratinocyte-specific caspase-1- or mature 
IL-18-transgenic mice have elevated serum levels of SAA and dense amyloid deposition in 
the liver, kidney, and spleen,
24
 suggesting that persistent skin inflammation could trigger
SA. Since IL-18 signalling is able to activate NF-κB
25
, epidermal keratinocytes and dermal
fibroblasts in the mice might continuously produce SAA via NF-κB. 
Patients with RDEB have persistently higher serum levels of SAA.
18
 They also
have widespread persistent skin ulcers, and keratinocytes and fibroblasts surrounding the 
ulcer lesions are continuously exposed to PAMPs and DAMPs. Therefore, the elevation of 
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SAA in the sera of RDEB patients might be due to TLR-mediated SAA production by 
keratinocytes and fibroblasts of persistent, widespread skin ulcers. 
In summary, we have shown here that TLR ligands induce the expression of SAA 
via NF-κB in epidermal keratinocytes and dermal fibroblasts, and that SAA further induces 
the expression of SAA itself via TLR1/2 and NF-κB in dermal fibroblasts. Our results 
provide new evidence that the skin’s innate immune response contributes to the 
upregulation of SAA expression, and the overproduction might lead to the increase in the 
risk of systemic complication such as SA of RDEB patients. 
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FIGURE LEGENDS 
Figure 1. TLR ligands induce the expression of SAA in epidermal keratinocytes and 
dermal fibroblasts. 
NHEKs (passage 4) or NHDFs (passage 7) at 80% confluency were stimulated with TLR 
ligands for 24 h. Relative SAA1/2 mRNA abundance was analysed by qPCR, and protein 
expression of SAA in the media was measured by ELISA. (a-d) *p<0.05, **p<0.01, 
***p<0.001. Data are given as mean ± SEM of triplicate samples and are representative of 
three independent experiments. 
Figure 2. Induction of SAA expression by TLR ligands in epidermal keratinocytes and 
dermal fibroblasts is NF-κB-dependent. 
The expression of p65 was knocked down by the specific siRNA in NHEKs (passage 7) at 
80% confluency and NHDFs (passage 7) at 60% confluency. Cells were then stimulated 
with TLR ligands for 24 h. The relative p65 (RELA) (a, b) and SAA1/2 (c, d) mRNA 
abundance was analysed by qPCR. *p<0.05, **p<0.01, ***p<0.001. Data are given as 
mean ± SEM of triplicate samples and are representative of three independent experiments. 
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Figure 3. SAA induces the expression of SAA itself through NF-κB in dermal 
fibroblasts. 
NHDFs (passage 8) at 80% confluency were stimulated with SAA (10
-8
 – 10
-6
 M) for 24 h.
Relative SAA1/2 mRNA abundance was analysed by qPCR. (a) The expression of p65 was 
knocked down by the specific siRNA in NHDFs (passage 7) at 70% confluency. Cells were 
then stimulated with SAA (10
-6
 M) for 24 h. Relative SAA1/2 mRNA abundance was
analysed by qPCR (b). **p<0.01. Data are given as mean ± SEM of triplicate samples and 
are representative of three independent experiments. 
Figure 4. Induction of SAA expression by SAA in dermal fibroblasts is 
TLR1/2-dependent. 
The expression of TLR1 or TLR2 was knocked down by the specific siRNA in NHDFs 
(passage 5) at 80% confluency (a, b). Cells were then stimulated with SAA (10
-6
 M) for 24
h. Relative SAA1/2 mRNA abundance was analysed by qPCR (c). NHDFs (passage 6) at
80% confluency were incubated with TLR1- or TLR2-neutralizing antibody for 30 min. 
Cells were then stimulated with SAA (10
-6
 M) for 24 h. Relative SAA1/2 mRNA abundance
was analysed by qPCR (d). *p<0.05, **p<0.01, ***p<0.001. Data are given as mean ± 
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SEM of triplicate samples and are representative of three independent experiments. 
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